世界のアポモルヒネ塩酸塩注射市場2020年:製造業者別、地域別、種類・用途別

【英語タイトル】Global Apomorphine Hydrochloride Injection Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20DC0600)・商品コード:GIR20DC0600
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年12月
・ページ数:108
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2~3日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥793,440見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、アポモルヒネ塩酸塩注射の世界市場を広く調査・分析し、今後の市場展望をまとめております。アポモルヒネ塩酸塩注射の種類別市場規模(ペンインジェクター、輸液ポンプ)、用途別市場規模(パーキンソン病、勃起不全)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Supernus Pharmaceuticals、Evolan Pharma AB (PharmSwed)、Britannia Pharmaceuticals STADA、Ever Pharma
・地域別グローバル市場分析 2015年-2020年
・アポモルヒネ塩酸塩注射の北米市場(アメリカ、カナダ、メキシコ)
・アポモルヒネ塩酸塩注射のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・アポモルヒネ塩酸塩注射のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・アポモルヒネ塩酸塩注射の南米市場(ブラジル、アルゼンチン)
・アポモルヒネ塩酸塩注射の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ペンインジェクター、輸液ポンプ
・用途別分析:パーキンソン病、勃起不全
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The Apomorphine Hydrochloride Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Apomorphine Hydrochloride Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Apomorphine Hydrochloride Injection market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Apomorphine Hydrochloride Injection market has been segmented into
Pen Injectors
Infusion Pumps

By Application, Apomorphine Hydrochloride Injection has been segmented into:
Parkinson Disease
Erectile Dysfunction

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Apomorphine Hydrochloride Injection market presented in the report. This section sheds light on the sales growth of different regional and country-level Apomorphine Hydrochloride Injection markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Apomorphine Hydrochloride Injection market.

The report offers in-depth assessment of the growth and other aspects of the Apomorphine Hydrochloride Injection market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Apomorphine Hydrochloride Injection Market Share Analysis
Apomorphine Hydrochloride Injection competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Apomorphine Hydrochloride Injection sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Apomorphine Hydrochloride Injection sales, revenue and market share for each player covered in this report.

The major players covered in Apomorphine Hydrochloride Injection are:
Supernus Pharmaceuticals
Evolan Pharma AB (PharmSwed)
Britannia Pharmaceuticals STADA
Ever Pharma

Among other players domestic and global, Apomorphine Hydrochloride Injection market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Apomorphine Hydrochloride Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Apomorphine Hydrochloride Injection, with price, sales, revenue and global market share of Apomorphine Hydrochloride Injection in 2018 and 2019.
Chapter 3, the Apomorphine Hydrochloride Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Apomorphine Hydrochloride Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Apomorphine Hydrochloride Injection market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Apomorphine Hydrochloride Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Apomorphine Hydrochloride Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Apomorphine Hydrochloride Injection Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Pen Injectors
1.2.3 Infusion Pumps
1.3 Market Analysis by Application
1.3.1 Overview: Global Apomorphine Hydrochloride Injection Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Overview of Global Apomorphine Hydrochloride Injection Market
1.4.1 Global Apomorphine Hydrochloride Injection Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Supernus Pharmaceuticals
2.1.1 Supernus Pharmaceuticals Details
2.1.2 Supernus Pharmaceuticals Major Business
2.1.3 Supernus Pharmaceuticals SWOT Analysis
2.1.4 Supernus Pharmaceuticals Product and Services
2.1.5 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Evolan Pharma AB (PharmSwed)
2.2.1 Evolan Pharma AB (PharmSwed) Details
2.2.2 Evolan Pharma AB (PharmSwed) Major Business
2.2.3 Evolan Pharma AB (PharmSwed) SWOT Analysis
2.2.4 Evolan Pharma AB (PharmSwed) Product and Services
2.2.5 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Britannia Pharmaceuticals STADA
2.3.1 Britannia Pharmaceuticals STADA Details
2.3.2 Britannia Pharmaceuticals STADA Major Business
2.3.3 Britannia Pharmaceuticals STADA SWOT Analysis
2.3.4 Britannia Pharmaceuticals STADA Product and Services
2.3.5 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ever Pharma
2.4.1 Ever Pharma Details
2.4.2 Ever Pharma Major Business
2.4.3 Ever Pharma SWOT Analysis
2.4.4 Ever Pharma Product and Services
2.4.5 Ever Pharma Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Apomorphine Hydrochloride Injection Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Apomorphine Hydrochloride Injection Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Apomorphine Hydrochloride Injection Manufacturer Market Share in 2019
3.3.2 Top 6 Apomorphine Hydrochloride Injection Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Apomorphine Hydrochloride Injection Sales, Revenue and Market Share by Regions
4.1.1 Global Apomorphine Hydrochloride Injection Sales and Market Share by Regions (2015-2020)
4.1.2 Global Apomorphine Hydrochloride Injection Revenue and Market Share by Regions (2015-2020)
4.2 North America Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
4.3 Europe Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
4.5 South America Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Apomorphine Hydrochloride Injection Sales, Revenue and Market Share by Country
5.1.1 North America Apomorphine Hydrochloride Injection Sales and Market Share by Country (2015-2020)
5.1.2 North America Apomorphine Hydrochloride Injection Revenue and Market Share by Country (2015-2020)
5.2 United States Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
5.3 Canada Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
5.4 Mexico Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Apomorphine Hydrochloride Injection Sales, Revenue and Market Share by Country
6.1.1 Europe Apomorphine Hydrochloride Injection Sales and Market Share by Country (2015-2020)
6.1.2 Europe Apomorphine Hydrochloride Injection Revenue and Market Share by Country (2015-2020)
6.2 Germany Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
6.3 UK Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
6.4 France Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
6.5 Russia Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
6.6 Italy Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Apomorphine Hydrochloride Injection Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Apomorphine Hydrochloride Injection Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Apomorphine Hydrochloride Injection Revenue and Market Share by Regions (2015-2020)
7.2 China Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
7.3 Japan Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
7.4 Korea Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
7.5 India Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
7.7 Australia Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Apomorphine Hydrochloride Injection Sales, Revenue and Market Share by Country
8.1.1 South America Apomorphine Hydrochloride Injection Sales and Market Share by Country (2015-2020)
8.1.2 South America Apomorphine Hydrochloride Injection Revenue and Market Share by Country (2015-2020)
8.2 Brazil Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
8.3 Argentina Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Apomorphine Hydrochloride Injection Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Apomorphine Hydrochloride Injection Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Apomorphine Hydrochloride Injection Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
9.3 Turkey Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
9.4 Egypt Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
9.5 South Africa Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Apomorphine Hydrochloride Injection Sales and Market Share by Type (2015-2020)
10.2 Global Apomorphine Hydrochloride Injection Revenue and Market Share by Type (2015-2020)
10.3 Global Apomorphine Hydrochloride Injection Price by Type (2015-2020)
11 Global Apomorphine Hydrochloride Injection Market Segment by Application
11.1 Global Apomorphine Hydrochloride Injection Sales Market Share by Application (2015-2020)
11.2 Global Apomorphine Hydrochloride Injection Revenue Market Share by Application (2015-2020)
11.3 Global Apomorphine Hydrochloride Injection Price by Application (2015-2020)
12 Market Forecast
12.1 Global Apomorphine Hydrochloride Injection Sales, Revenue and Growth Rate (2021-2025)
12.2 Apomorphine Hydrochloride Injection Market Forecast by Regions (2021-2025)
12.2.1 North America Apomorphine Hydrochloride Injection Market Forecast (2021-2025)
12.2.2 Europe Apomorphine Hydrochloride Injection Market Forecast (2021-2025)
12.2.3 Asia-Pacific Apomorphine Hydrochloride Injection Market Forecast (2021-2025)
12.2.4 South America Apomorphine Hydrochloride Injection Market Forecast (2021-2025)
12.2.5 Middle East & Africa Apomorphine Hydrochloride Injection Market Forecast (2021-2025)
12.3 Apomorphine Hydrochloride Injection Market Forecast by Type (2021-2025)
12.3.1 Global Apomorphine Hydrochloride Injection Sales Forecast by Type (2021-2025)
12.3.2 Global Apomorphine Hydrochloride Injection Market Share Forecast by Type (2021-2025)
12.4 Apomorphine Hydrochloride Injection Market Forecast by Application (2021-2025)
12.4.1 Global Apomorphine Hydrochloride Injection Sales Forecast by Application (2021-2025)
12.4.2 Global Apomorphine Hydrochloride Injection Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Apomorphine Hydrochloride Injection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Apomorphine Hydrochloride Injection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Apomorphine Hydrochloride Injection Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Apomorphine Hydrochloride Injection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Supernus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Major Business
Table 10. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Total Revenue (USD Million) (2018-2019)
Table 11. Supernus Pharmaceuticals SWOT Analysis
Table 12. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Product and Services
Table 13. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Evolan Pharma AB (PharmSwed) Basic Information, Manufacturing Base and Competitors
Table 15. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Major Business
Table 16. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Total Revenue (USD Million) (2018-2019)
Table 17. Evolan Pharma AB (PharmSwed) SWOT Analysis
Table 18. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Product and Services
Table 19. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Britannia Pharmaceuticals STADA Basic Information, Manufacturing Base and Competitors
Table 21. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Major Business
Table 22. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Total Revenue (USD Million) (2018-2019)
Table 23. Britannia Pharmaceuticals STADA SWOT Analysis
Table 24. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Product and Services
Table 25. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Ever Pharma Basic Information, Manufacturing Base and Competitors
Table 27. Ever Pharma Apomorphine Hydrochloride Injection Major Business
Table 28. Ever Pharma Apomorphine Hydrochloride Injection Total Revenue (USD Million) (2018-2019)
Table 29. Ever Pharma SWOT Analysis
Table 30. Ever Pharma Apomorphine Hydrochloride Injection Product and Services
Table 31. Ever Pharma Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Global Apomorphine Hydrochloride Injection Sales by Manufacturer (2018-2019) (K Units)
Table 33. Global Apomorphine Hydrochloride Injection Revenue by Manufacturer (2018-2019) (USD Million)
Table 34. Global Apomorphine Hydrochloride Injection Sales by Regions (2015-2020) (K Units)
Table 35. Global Apomorphine Hydrochloride Injection Sales Market Share by Regions (2015-2020)
Table 36. Global Apomorphine Hydrochloride Injection Revenue by Regions (2015-2020) (USD Million)
Table 37. North America Apomorphine Hydrochloride Injection Sales by Countries (2015-2020) (K Units)
Table 38. North America Apomorphine Hydrochloride Injection Sales Market Share by Countries (2015-2020)
Table 39. North America Apomorphine Hydrochloride Injection Revenue by Countries (2015-2020) (USD Million)
Table 40. North America Apomorphine Hydrochloride Injection Revenue Market Share by Countries (2015-2020)
Table 41. Europe Apomorphine Hydrochloride Injection Sales by Countries (2015-2020) (K Units)
Table 42. Europe Apomorphine Hydrochloride Injection Sales Market Share by Countries (2015-2020)
Table 43. Europe Apomorphine Hydrochloride Injection Revenue by Countries (2015-2020) (USD Million)
Table 44. Asia-Pacific Apomorphine Hydrochloride Injection Sales by Regions (2015-2020) (K Units)
Table 45. Asia-Pacific Apomorphine Hydrochloride Injection Sales Market Share by Regions (2015-2020)
Table 46. Asia-Pacific Apomorphine Hydrochloride Injection Revenue by Regions (2015-2020) (USD Million)
Table 47. South America Apomorphine Hydrochloride Injection Sales by Countries (2015-2020) (K Units)
Table 48. South America Apomorphine Hydrochloride Injection Sales Market Share by Countries (2015-2020)
Table 49. South America Apomorphine Hydrochloride Injection Revenue by Countries (2015-2020) (USD Million)
Table 50. South America Apomorphine Hydrochloride Injection Revenue Market Share by Countries (2015-2020)
Table 51. Middle East & Africa Apomorphine Hydrochloride Injection Sales by Countries (2015-2020) (K Units)
Table 52. Middle East & Africa Apomorphine Hydrochloride Injection Sales Market Share by Countries (2015-2020)
Table 53. Middle East & Africa Apomorphine Hydrochloride Injection Revenue by Countries (2015-2020) (USD Million)
Table 54. Middle East & Africa Apomorphine Hydrochloride Injection Revenue Market Share by Countries (2015-2020)
Table 55. Global Apomorphine Hydrochloride Injection Sales by Type (2015-2020) (K Units)
Table 56. Global Apomorphine Hydrochloride Injection Sales Share by Type (2015-2020)
Table 57. Global Apomorphine Hydrochloride Injection Revenue by Type (2015-2020) (USD Million)
Table 58. Global Apomorphine Hydrochloride Injection Revenue Share by Type (2015-2020)
Table 59. Global Apomorphine Hydrochloride Injection Sales by Application (2015-2020) (K Units)
Table 60. Global Apomorphine Hydrochloride Injection Sales Share by Application (2015-2020)
Table 61. Global Apomorphine Hydrochloride Injection Sales Forecast by Regions (2021-2025) (K Units)
Table 62. Global Apomorphine Hydrochloride Injection Market Share Forecast by Regions (2021-2025)
Table 63. Global Apomorphine Hydrochloride Injection Sales Forecast by Type (2021-2025) (K Units)
Table 64. Global Apomorphine Hydrochloride Injection Market Share Forecast by Type (2021-2025)
Table 65. Global Apomorphine Hydrochloride Injection Sales Forecast by Application (2021-2025)
Table 66. Global Apomorphine Hydrochloride Injection Market Share Forecast by Application (2021-2025)
Table 67. Direct Channel Pros & Cons
Table 68. Indirect Channel Pros & Cons
Table 69. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Apomorphine Hydrochloride Injection Picture
Figure 2. Global Sales Market Share of Apomorphine Hydrochloride Injection by Type in 2019
Figure 3. Pen Injectors Picture
Figure 4. Infusion Pumps Picture
Figure 5. Apomorphine Hydrochloride Injection Sales Market Share by Application in 2019
Figure 6. Parkinson Disease Picture
Figure 7. Erectile Dysfunction Picture
Figure 8. Global Apomorphine Hydrochloride Injection Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Apomorphine Hydrochloride Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Apomorphine Hydrochloride Injection Sales Market Share by Manufacturer in 2019
Figure 29. Global Apomorphine Hydrochloride Injection Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Apomorphine Hydrochloride Injection Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Apomorphine Hydrochloride Injection Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Apomorphine Hydrochloride Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Apomorphine Hydrochloride Injection Revenue Market Share by Regions (2015-2020)
Figure 36. Global Apomorphine Hydrochloride Injection Revenue Market Share by Regions in 2018
Figure 37. North America Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
Figure 38. Europe Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
Figure 40. South America Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020)
Figure 42. North America Apomorphine Hydrochloride Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Apomorphine Hydrochloride Injection Sales Market Share by Countries (2015-2020)
Figure 44. North America Apomorphine Hydrochloride Injection Sales Market Share by Countries in 2018
Figure 45. North America Apomorphine Hydrochloride Injection Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Apomorphine Hydrochloride Injection Revenue Market Share by Countries in 2018
Figure 47. United States Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Apomorphine Hydrochloride Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Apomorphine Hydrochloride Injection Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Apomorphine Hydrochloride Injection Revenue Market Share by Countries in 2019
Figure 53. Germany Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Apomorphine Hydrochloride Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Apomorphine Hydrochloride Injection Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Apomorphine Hydrochloride Injection Revenue Market Share by Regions 2019
Figure 61. China Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Apomorphine Hydrochloride Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Apomorphine Hydrochloride Injection Sales Market Share by Countries in 2019
Figure 68. South America Apomorphine Hydrochloride Injection Revenue Market Share by Countries in 2019
Figure 69. Brazil Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Apomorphine Hydrochloride Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Apomorphine Hydrochloride Injection Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Apomorphine Hydrochloride Injection Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Apomorphine Hydrochloride Injection Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Apomorphine Hydrochloride Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Apomorphine Hydrochloride Injection Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Apomorphine Hydrochloride Injection Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Apomorphine Hydrochloride Injection Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Apomorphine Hydrochloride Injection Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Apomorphine Hydrochloride Injection Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Apomorphine Hydrochloride Injection Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Apomorphine Hydrochloride Injection Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Supernus Pharmaceuticals、Evolan Pharma AB (PharmSwed)、Britannia Pharmaceuticals STADA、Ever Pharma

★調査レポート[世界のアポモルヒネ塩酸塩注射市場2020年:製造業者別、地域別、種類・用途別] (コード:GIR20DC0600)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアポモルヒネ塩酸塩注射市場2020年:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆